efflux resistant breaker antibiotics (King's College London/Public Health England)

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug Nameefflux resistant breaker antibiotics (King's College London/Public Health England)
Drug Alias Nameantibiotic resistance breaker-antibiotic hybrids (King's College London/Public Health England)efflux resistant breaker antibiotics (Necobiotix)antibiotic resistance breaker-antibiotic hybrids (NecoBiotix)KCL-ARB1KSN-L22 +[9] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionAntibacterial multidrug resistance inhibitorsBacterial DNA gyrase inhibitors
TargetsBacterial DNA gyrase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKing'S College London
China Registration ClassN/A

Develop Information

Active CompaniesNecoBiotix Ltd
Inactive CompaniesPublic Health EnglandKing'S College London
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A